Price movement over the last 24 hours
Bio Protocol vs Hyperlane — how do they compare? Bio Protocol trades at Rp521.85 (market cap Rp1,17T, Rp248,44M 24h volume), while Hyperlane trades at Rp1,220 (market cap Rp412,23M, Rp163,51M 24h volume). The key difference: Bio Protocol is far larger — about 2838.2× Hyperlane's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 338,2M / 1B HYPER (34%) for Hyperlane. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Hyperlane for 30 Days on average.
| BIO | HYPER | |
|---|---|---|
Market Cap | Rp1,17T | Rp412,23M |
Volume (24h) | Rp248,44M | Rp163,51M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 338,2M / 1B HYPER (34%) |
Typical Hold Time | 16 Days | 30 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp521.46 with a market cap of Rp1.16T, showing bearish technical signals as moving averages indicate selling pressure while oscillators remain neutral. The token's circulating supply of 2.2M out of 3.3M max supply (68% circulation) suggests controlled token distribution. Current price sits near the pivot point of Rp521 with immediate support at Rp508 and resistance at Rp530. Recent market activity shows average hold time of 16 days, indicating relatively short-term trading patterns in the current bearish environment.
Overall outlook remains cautious with technical indicators favoring sellers, though oversold RSI conditions may present short-term bounce opportunities. Key risks include continued bearish momentum and low trading volumes, while potential upside could come from any positive ecosystem developments or market-wide crypto recovery. Investors should monitor support levels closely for entry points.
Hyperlane (HYPER) is currently trading at Rp1,226, showing a bearish technical outlook with moving averages signaling strong selling pressure, while oscillators are neutral. The asset is trading near key support levels, with immediate support at Rp1,195 and resistance at Rp1,277. No major protocol updates or ecosystem developments have been reported recently.
Overall outlook remains cautious due to bearish technicals and limited fundamental catalysts. Key opportunities include potential rebounds from oversold RSI levels, but risks include low liquidity, high volatility, and the absence of recent positive developments. Investors should monitor for any ecosystem updates or shifts in market sentiment.
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Hyperlane is an innovative interoperability layer designed to connect the modular blockchain ecosystem. It facilitates seamless communication across different blockchain environments, including Layer 1s, rollups, and app-chains. Created for permissionless deployment, Hyperlane enables developers to easily bridge chains while providing customizable security models tailored to the specific requirements of their applications.
Read more on HYPER →